Skip to main content

Vaccine Development for Novel Coronavirus Response

Loading Presentations

« All Presentations

  • This agenda has passed.

Vaccine Development for Novel Coronavirus Response

June 18, 2020 at 10:00 AM - 11:15 AM

The spread of SARS-CoV-2 and the resulting COVID-19 pandemic has had wide-reaching effects that require a multifaceted response. Accelerating vaccine development and distribution is a key component in responding to this emerging pathogen. Vaccine development typically takes decades from research and development to implementation, so having licensed and approved vaccines available for mass distribution in a 12-18 month timeframe would be unprecedented. However, advances in science along with new manufacturing platforms may allow the development of new vaccines against COVID-19. This session will discuss current efforts underway to develop vaccines to combat this public health threat.


June 18, 2020
10:00 AM - 11:15 AM


Kayvon Modjarrad, MD, PhD
Job Title:
Director, Emerging Infectious Diseases Branch
Walter Reed Army Institute of Research
Beth P. Bell, MD, MPH
Job Title:
NFID Director; Clinical Professor, Department of Global Health, School of Public Health
University of Washington
Barney S. Graham, MD, PhD
Job Title:
Deputy Director, Vaccine Research Center
National Institutes of Health
Kathleen M. Neuzil, MD, MPH
Job Title:
ACVR Vice Chair; NFID Director; Myron M. Levine Professor in Vaccinology and Director, Center for Vaccine Development and Global Health
University of Maryland School of Medicine